US-based telehealth services provider VSee Health has teamed up with intelligent robot maker Ava Robotics to develop telepresence solutions for the inpatient intensive care market.
The collaboration aims to develop a VSee-powered Ava robot that enables healthcare providers to extend their reach and offer personalised care remotely.
The Ava Robot, powered by VSee software, is anticipated to expand the reach of telehealth solutions beyond large hospitals, making it accessible to regional hospitals and smaller ICUs.
VSee Health co-CEO and chairman Imo Aisiku said: “Telehealth is among the most innovative advancements in medicine in the 21st century.
“Our goal under this new agreement with Ava Robotics is to make the best critical care in the world available to every ICU in the country.
“We have the best-trained physicians in the world, and by integrating with Ava’s robotics we will be able to extend their reach and expertise to patients throughout the United States.”
VSee Health is a software-as-a-service (SaaS) platform that helps clinicians and enterprises create telehealth workflows and integrate them into existing hospital operations.
The company has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform.
The technology includes a set of integrated telehealth technologies and a team of neuro intensivists, neurologists, and tele-radiologists to manage care for severely ill patients.
VSee Health said that the Ava Robot will be autonomous in the hospital intensive care unit (ICU), enabling skilled physicians to have a physical presence at the point of patient care.
The medical robot will interact with patients, consult with hospital staff, and make real-time treatment decisions, said the telehealth services provider.
Aisiku added: “Not only will patients receive the best expertise available and better care, regardless of location, but hospitals will be able to deliver a new, heightened level of care, reducing transfers and costs associated with critical care and stroke.
“With the first commercial product launched in June, the Ava Robot is expected to be able to improve tele-stroke operations, and additional uses will be identified in the medical field as use of the Robot expands.”
